ADEA Advocate, the official newsletter of the American Dental Education Association, reports that 10 states have jointly filed a lawsuit against the U.S. Centers for Medicare and Medicaid Services (CMS) challenging the agency’s COVID-19…

Despite widespread access to COVID-19 vaccines, Europe is experiencing a fall surge in COVID-19 cases, forcing many countries to implement lockdown measures once again. Case rates have jumped by as much as 50% in some areas, and the…

One of the most confounding aspects of COVID-19 illness is why some people become gravely ill while others show no symptoms. Part of this conundrum is also why a percentage of those who recover from SARS-CoV-2 infection still face long-term…

The final COVID-19 vaccine mandate issued by Maine’s Governor Janet Mills does not include dental healthcare providers due to evidence demonstrating that the state’s dental offices were not hot spots for the transmission of COVID-19. Other…

An antibody COVID-19 medication, Sotrovimab—created by GSK and Vir—that originally required administration via infusion can now be given as an intramuscular injection, significantly improving its ease of use. Data from a new study show the…

For decades W&H's sales team has been providing dental products and solutions to the US market. To further strengthen their global brand in North America, they have expanded their US team to deliver broader, more localized support in…

The United States Centers for Medicare & Medicaid Services announced that all employees of healthcare facilities that accept payment from Medicare and/or Medicaid must be vaccinated against COVID-19 by January 4, 2022. There is no…

StarAligners Promotes John Nabors to Vice President of Operations and Sales

Dentists can increase the profitability of their dental practice by understanding important financial principles, implementing solid planning strategies and by having the right people, processes and tools in place. In this episode of The…

The United States government committed to purchasing 1.7 million doses of molnupiravir—the Merck antiviral medication for COVID-19—in June, and has since increased its order by 1.4 million doses. Molnupiravir has been shown to decrease…